Drug could be promising new option against eczema
A pill called upadacitinib, already approved for treating rheumatoid arthritis, might also ease another common immunological condition—eczema.
by ·
A pill called upadacitinib, already approved for treating rheumatoid arthritis, might also ease another common immunological condition—eczema.
by · Published June 21, 2021
by · Published April 15, 2021
by · Published May 26, 2021